600535.SH
Tasly Pharmaceutical Group Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 13.65
−0.36%Next report
Analyst consensus
- Next report date
- Mar 30, 2027
- EPS estimate
- CNY 0.28
- Revenue estimate
- CNY 1.9B
Latest reported
- Last report date
- Oct 23, 2026
- EPS actual
- CNY 0.23
- EPS estimate
- CNY 0.23
- Revenue actual
- CNY 1.9B
- Revenue estimate
- CNY 1.9B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +0.0%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 23, 2026 | CNY 0.23 | CNY 0.23 | In line | CNY 1.9B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027